Search by Drug Name or NDC
NDC 00054-0062-58 Citalopram 10 mg/5mL Details
Citalopram 10 mg/5mL
Citalopram is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is CITALOPRAM HYDROBROMIDE.
MedlinePlus Drug Summary
Citalopram is used to treat depression. Citalopram is in a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs). It works by increasing the amount of serotonin, a natural substance in the brain that helps maintain mental balance.
Related Packages: 00054-0062-58Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Citalopram
Product Information
| NDC | 00054-0062 |
|---|---|
| Product ID | 0054-0062_6a701183-6c4f-448f-a05a-81ee7f5b734f |
| Associated GPIs | 58160020102020 |
| GCN Sequence Number | 046205 |
| GCN Sequence Number Description | citalopram hydrobromide SOLUTION 10 MG/5 ML ORAL |
| HIC3 | H2S |
| HIC3 Description | SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRIS) |
| GCN | 16344 |
| HICL Sequence Number | 010321 |
| HICL Sequence Number Description | CITALOPRAM HYDROBROMIDE |
| Brand/Generic | Generic |
| Proprietary Name | Citalopram |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Citalopram |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/5mL |
| Substance Name | CITALOPRAM HYDROBROMIDE |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA077043 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00054-0062-58 (00054006258)
| NDC Package Code | 0054-0062-58 |
|---|---|
| Billing NDC | 00054006258 |
| Package | 1 BOTTLE, PLASTIC in 1 CARTON (0054-0062-58) / 240 mL in 1 BOTTLE, PLASTIC |
| Marketing Start Date | 2004-05-25 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.20946 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | CITALOPRAM HBR 10 MG/5 ML SOLN |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis